InvestorsHub on MSN
Theralase and Ferring ink deal for new bladder cancer study
Theralase Technologies (USOTC:TLTFF) signed a clinical development agreement with Ferring Pharmaceuticals, a top name in ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the Saudi Food and Drug ...
Stocktwits on MSN
IBRX stock finds retail cheer after company’s immunotherapy for bladder cancer gets Saudi FDA approval
ImmunityBio plans to establish a regional office in Saudi Arabia to support its expansion across the Middle East and North ...
The collaborative clinical study will evaluate ADSTILADRIN® (nadofaragene firadenovec-vncg) in combination with the ...
While the current approval focuses on the second-line setting, research is already moving into earlier stages of the disease.The ongoing SunRISe-3 trial (NCT05714202) is testing TAR-200 head-to-head ...
A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...
The Middle and Friends actor Pat Finn’s cause of death has been released after he died on Dec. 22 at the age of 60. The ...
The number and frequency of intravesical instillations for non-muscle-invasive bladder cancer (NMIBC) impairs quality of life and needs to be reported in clinical trials.
New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...
Swelling in the legs may indicate serious health problems, such as cancer in the bladder, especially when accompanied by other symptoms. Unfortunately, awareness of some rather unusual symptoms of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results